FABIAN DAMMANN: Open Payments
NPI 1407377104 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 18 payments from 4 companies in 2025. Trend: 2023 $421 · 2024 $485 · 2025 $792
Food & beverage: $764Long term medical supply or device loan: $28
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 13 | $666 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| ViiV Healthcare Company | 1 | $47 |
| Baxter Healthcare | 1 | $28 |
Products named: Epclusa, Biktarvy, PIFELTRO, CABENUVA, Hillrom - ELI 280.
Industry payments across NJ — which companies pay providers there.
